A recent study by Reichiling et al. suggests that the prognosis evaluation of CRC acquires further insight into the stromal immune infiltration (CD3+ and CD8+ T-cells) in addition to intrinsic tumor variables [25]. The gene discussed is CD8A; the disease is colorectal carcinoma.